Knott David M Jr »

Pelthos Therapeutics shares owned by Knott David M Jr

Quarter-by-quarter ownership of Pelthos Therapeutics shares owned by Knott David M Jr from 13F filings

Historical chart of Knott David M Jr investment in Pelthos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Pelthos Therapeutics held by Knott David M Jr consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pelthos Therapeutics by Knott David M Jr

Quarter filed Position value Share count Share price at filing
2025-09-30 $171k 6.1k 28.00

More positions owned by Knott David M Jr

Calumet Common (CLMT)
Apollo Global Management Common (APO)
Alphabet Inc-Cl C Common (GOOG)
Janus Henderson AAA CLO ETF Common (JAAA)
Darling Ingredients Common Call Option (DAR)
Xeris Biopharma Holdings Common (XERS)
Syndax Pharmaceutical Common (SNDX)
JPMorgan Chase & Co. Common (JPM)
Travere Therapeutics Common (TVTX)
Avadel Pharmaceuticals Common (AVDL)
Protagonist Therapeutics Common (PTGX)
Bridgebio Pharma Common (BBIO)
DocGo Common (DCGO)
Verona Pharma Common (VRNA)
LENZ Therapeutics Common (LENZ)

View all positions for Knott David M Jr

Top funds holding Pelthos Therapeutics

Murchinson
Vanguard Group
Ikarian Capital
Boothbay Fund Management
Diadema Partners
Geode Capital Management
Knott David M Jr
Steward Partners Investment Advisory
Tower Research Capital
UBS Group
Jpmorgan Chase & Co

View all funds holding Pelthos Therapeutics